Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.Baituxiao Botanical Formula: Product, Label and Evidence Profile
Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read moreGabapentin as an Adjunct in Cancer Pain Plans
Gabapentin may be one component of multimodal pain or anxiety support, but effectiveness varies and sedation, weakness, kidney function, and compounded products need review.
Read morePregabalin as a Neuropathic-Pain Adjunct: Evidence and Sedation Review
Pregabalin is a prescription neuromodulator considered for selected pain plans, with limited oncology-specific evidence and meaningful sedation and coordination risks.
Read moreAmantadine in Multimodal Cancer Pain Care
Amantadine may be used as an adjunct for selected chronic pain mechanisms, but veterinary cancer-specific evidence and patient response are limited and individualized.
Read moreVeterinary NSAIDs in Oncology: Pain, Inflammation, and Interaction Safety
A veterinary NSAID may support pain and inflammation and has tumor-specific roles in selected plans, but the exact product, species label, organ risk, and drug combinations govern safety.
Read moreOpioids in Veterinary Cancer Pain and Crisis Care
Opioids are controlled prescription analgesics used in selected acute, severe, perioperative, and palliative pain plans under route-, product-, and jurisdiction-specific oversight.
Read moreBisphosphonates for Tumor-Associated Bone Pain
Intravenous bisphosphonates may be considered for selected tumor-associated bone pain or skeletal complications, with kidney, mineral, dental, and infusion review.
Read more
Medicinal Mushroom Extracts: Product-Specific Oncology Evidence
Mushroom products differ by species, extracted fraction, standardization, contaminants, and evidence; the word mushroom does not identify a tested intervention.
Read moreTurmeric and Curcumin: Bioavailability, Interaction, and Evidence Limits
Turmeric and curcumin products vary in extract, concentration, absorption enhancers, and purity, while robust canine cancer outcome evidence is lacking.
Read moreCBD and Cannabis Products in Pets With Cancer: Regulatory and Safety Boundary
FDA has not approved CBD for animal use, and product quality, THC contamination, interactions, liver effects, sedation, legal status, and cancer claims require caution.
Read more